Patient care

Patient care

Photo of Ian Windmill

PRESIDENT'S MESSAGE | Expanding Our Profession

The past 18 months have been nothing if not interesting for our profession. Between PCAST, the FDA, and the National Academy of Sciences, there have been multiple recommendations and suggestions regarding improving the access to, and affordability of, hearing care. More recently, the FTC announced that they too would be reviewing the delivery of hearing care, from their perspective as a consumer protection agency. And a bill has just been introduced in Congress that directs the FDA to develop rules for an over-the-counter hearing device. 

Topic(s): Patient care, over-the-counter (OTC) hearing aid devices, Advocacy, audiology

Author(s): 

Publication Issue: Audiology Today May/June 2017

Call Me Doctor: Opinion Editorial

By 

Read more

Photo of audiologist greeting a patient before consultation.

ONLINE FEATURE | Call Me Doctor: Opinion Editorial

My dad suffered a stroke when I was in high school and part of his return to normalcy was working with a speech pathologist. I was fascinated by the process, and it led me to declare it as my major when I attended the University of Florida (UF) as an undergraduate. I was the first in my family to attend and graduate from college. 

Topic(s): Patient care, audiology

Illustrated Spondee word cloud

LETTER FROM THE EDITOR | Impending Spondee Crisis

In his website editorial titled “The Impending Spondee Crisis: Audiology in the Age of the Millennial,” published at www.audiology.org (June 14, 2016), author Frank Bialostozky is thinking in the right direction about the impending spondee crisis but his thinking doesn’t go far enough. 

Topic(s): spondee, audiology, Patient care

Author(s): 

Publication Issue: Audiology Today July/August 2017

Newborn Hearing Screening

ONLINE FEATURE | Newborn Hearing Screenings and Follow-Up: Essential During a Pandemic?

The primary objective of local, state, and federal response to COVID-19 is to minimize mortality and mitigate explosive demand for acute health-care services related to COVID-19 complications, especially those that require care in intensive care units. 

Governmental responses have varied from statewide stay-at-home orders to more incremental approaches targeting restrictions in specific industries and locations. Certainly, many of these restrictions are warranted and necessary to achieve the desired public health outcomes. 

Topic(s): COVID-19, Pediatric Audiology, pediatrics, Early Hearing Detection and Intervention (EHDI), Patient care, tele-audiology

Dietary Supplements with vegetables in the background

ONLINE FEATURE | Dietary Supplements Used for COVID-19 Treatment

There are no dietary supplements that will cure or prevent disease. With the 2019 coronavirus COVID-19 pandemic, it’s especially important to understand that no supplement, diet, or other lifestyle modification other than physical distancing, also known as social distancing, and proper hygiene practices can protect you from COVID-19.

There is no research to support the use of any dietary supplement to protect against COVID-19. No supplement may claim to diagnose, prevent, treat or cure COVID-19. Consumers and retailers should avoid products that suggest they do.1, 2

Topic(s): COVID-19, Ototoxicity, Patient care, diet, dietary supplements

Author(s): 

Publication Issue: Audiology Today May/June 2020

Ototoxicity of FDA-Approved Drugs Being Re-Purposed for COVID-19 Treatment

According to the National Institutes of Health’s Center National Center for Advancing Translational Sciences, many drugs approved for other uses already have been tested in humans, so detailed information is available on their pharmacology, formulation, and potential toxicity. 

Read more

Vestibular Testing Safety: COVID-19 and Beyond

All recommendations are made with the best current information and in the context of a multifaceted safety program. When a variety of safety measures are put in place our chance of protecting our patients and colleagues increases.

All safety recommendations assume that

Read more

Elderly Man with hearing loss

ONLINE FEATURE | Ototoxicity of FDA-Approved Drugs Being Re-Purposed for COVID-19 Treatment

According to the National Institutes of Health’s Center National Center for Advancing Translational Sciences, many drugs approved for other uses already have been tested in humans, so detailed information is available on their pharmacology, formulation, and potential toxicity. 

Topic(s): COVID-19, Ototoxicity, FDA, Patient care, Practice Management

Author(s): 

Publication Issue: Audiology Today May/June 2020

Surgical Monitoring Safety: COVID-19 and Beyond

Because of the potential to aerosolize the virus during drilling in the mastoid cavity, neurotological surgeries present a potentially high risk of contamination. Many audiologists monitor responses during cochlear implant surgeries or may provide intraoperative monitoring for other neurotological surgeries.

All recommendations are made with the best current information and in the context of a multifaceted safety program. When a variety of safety measures are put in place our chance of protecting our patients and colleagues increases.

All safety recommendations assume that

Read more